홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
TGTX
#1263
TG Therapeutics, Inc.
34.6
2
USD
+0.06%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+0.06%
월간 변동
+20.21%
6달 변화
+0.26%
년간 변동율
-8.92%
이전 종가
34.6
0
Open
34.5
6
Bid
Ask
Low
34.4
3
High
34.7
6
양
104
마켓
주식
헬스케어
TGTX
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
157.07 M
158.76 M
158.67 M
158.76 M
159.69 M
—
Valuation ratios
Enterprise value
4.79 B
6.37 B
5.83 B
5.91 B
4.93 B
23.03 B
Price to earnings ratio
200.67
157.72
94.71
12.95
10.76
276.14
Price to sales ratio
14.67
16.43
12.82
10.98
7.81
48.04
Price to cash flow ratio
-119.11
-104.44
-98.19
-83.16
-194.24
-480.03
Price to book ratio
21.7
7.65
6.27
4.34
7.43
25.69
EBITDA 비율에 대한 기업 가치
114.33
106.59
67.94
57.52
40
272.04
Profitability ratios
Return on assets %
0.04
0.01
0.04
0.38
0.02
0.45
Return on equity %
0.1
0.02
0.1
0.64
0.04
0.8
Return on invested capital %
62.39
14.03
47.39
346.1
13.84
421.36
Gross margin %
85.77
87.14
86.58
82.63
80.19
336.54
Operating margin %
27.68
7.13
24.69
18.16
26.22
76.2
EBITDA margin %
27.69
7.14
24.69
18.17
26.23
76.24
Net margin %
21.57
4.19
19.97
241.73
11.96
277.85
Liquidity ratios
Quick ratio
5.03
3.04
2.96
2.89
3.29
12.17
Current ratio
6.25
4.02
3.86
3.82
4.1
15.81
Inventory turnover
0.16
0.12
0.12
0.19
0.28
0.7
Asset turnover
0.19
0.2
0.21
0.19
0.18
0.78
Solvency ratios
Debt to assets ratio
0.42
0.37
0.35
0.24
0.23
1.19
Debt to equity ratio
1.1
1.03
0.89
0.4
0.38
2.7
Long term debt to total assets ratio
0.42
0.37
0.35
0.24
0.23
1.19
Long term debt to total equity ratio
1.1
1.03
0.89
0.4
0.38
2.7
Per share metrics
Operating cash flow per share
-0.16
-0.18
0.05
-0.14
0.12
-0.15
EBIT per share
0.19
0.05
0.21
0.18
0.31
0.76
EBITDA per share
0.19
0.05
0.21
0.18
0.31
0.76
Total debt per share
1.52
1.5
1.51
1.52
1.52
6.06
Cash per share
1.94
1.7
1.72
1.11
1.24
5.76
Net current asset value per share
3.53
3.96
4.08
3.73
3.91
15.68
Tangible book value per share
1.39
1.46
1.7
3.77
4.01
10.94
Working capital per share
2.97
2.98
3.03
2.75
2.96
11.71
Book value per share
1.39
1.46
1.7
3.77
4.01
10.94
뉴스
TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting Downside (TGTX)
브리움비, 다발성 경화증 환자에 효능 입증
BRIUMVI shows efficacy in highly active multiple sclerosis patients
TG 테라퓨틱스, 신경학회서 브리움비 데이터 발표
TG Therapeutics to present BRIUMVI data at neurology meeting
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
TG Therapeutics (TGTX) Misses Q4 Earnings Estimates
TG Q4 실적 에상치보다 저조, 수익 예상치를 넘어
TG earnings missed by $0.23, revenue topped estimates
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
TG Therapeutics faces earnings test as Briumvi growth accelerates
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release